KLRK1 and chronic myelogenous leukemia, BCR-ABL1 positive: We showed previously that an upregulation of NKG2D on Vγ9Vδ2+ T-cells expanded after exercise played a mechanistic role in improved killing of the U266 multiple myeloma cell line, but not against the K562 chronic myeloid leukemia cell line (10).